PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?

Neurology. 2016 Jul 26;87(4):440-1. doi: 10.1212/WNL.0000000000002900. Epub 2016 Jun 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Dimethyl Fumarate / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Leukoencephalopathy, Progressive Multifocal / diagnostic imaging
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Lymphopenia / chemically induced*
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Immunosuppressive Agents
  • Dimethyl Fumarate